Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis
2018 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis
Shahnaz Syed Abd Kadir, S.; Christopeit, M.; Wulf, G. ; Wagner, E. ; Bornhauser, M.; Schroeder, T. & Crysandt, M. et al. (2018)
European Journal of Haematology, 101(3) pp. 305-317. DOI: https://doi.org/10.1111/ejh.13099
Documents & Media
Details
- Authors
- Shahnaz Syed Abd Kadir, Sharifah; Christopeit, Maximilian; Wulf, Gerald ; Wagner, Eva ; Bornhauser, Martin; Schroeder, Thomas; Crysandt, Martina; Mayer, Karin; Jonas, Julia; Stelljes, Matthias; Badbaran, Anita; Ayuketang Ayuk, Francis; Triviai, Ioanna; Wolf, Dominik; Wolschke, Christine; Kröger, Nicolaus
- Issue Date
- 2018
- Journal
- European Journal of Haematology
- ISSN
- 0902-4441
- Language
- English
